The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy
The DOI matches its Crossref record.
Abstract
Aims To characterize symptom severity of diabetic peripheral neuropathy (DPN) in people with diabetes and to characterize its association with healthcare resource use. Methods The study was undertaken in Cardiff and the Vale of Glamorgan, UK. A postal survey was posted to subjects identified as having diabetes. Demography, quality of life (EQ‐5D and SF‐36) and symptoms of neuropathy (NTSS‐6 and QOL‐DN) data were collected. These data were linked to routine healthcare data coded into healthcare resource groups (HRGs) and subsequently costed according to UK National reference costs. Results Survey responses were received from 1298 patients, a 32% response rate. For patients with a clinically confirmed diagnosis of DPN, the mean NTSS‐6‐SA score was 6.16 vs. 3.19 (P < 0.001). Duration of diabetes did not change across groups defined by severity of neuropathy symptoms, but mean HbA 1c and body mass index values did increase with symptom severity (range 7.6–8.1%, P = 0.023; and 28.0–30.9 kg/m 2, P < 0.001, respectively). General linear modelling showed that the NTSS‐6‐SA score was a significant predictor of both annual health resource costs and yearly prescribed drug costs. On average, each 1‐point increase in NTSS‐6‐SA score predicted a 6% increase in primary and secondary care costs and a 3% increase in log transformed drug costs. Conclusion This study demonstrated that severity of DPN symptoms was associated with increased healthcare resource use, thus costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy
Tesfaye, S., & Selvarajah, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2239 · Cited by 615
Muka, T., Imo, D., Jaspers, L., Colpani, V., Chaker, L., van der Lee, S. J., Mendis, S., Chowdhury, R., Bramer, W. M., Falla, A., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-014-9984-2 · Cited by 373
Central nervous system involvement in diabetic neuropathy
Selvarajah, D., Wilkinson, I. D., Davies, J., Gandhi, R., & Tesfaye, S. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0205-z · Cited by 102
Heller, S., White, D., Lee, E., Lawton, J., Pollard, D., Waugh, N., Amiel, S., Barnard, K., Beckwith, A., Brennan, A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21200 · Cited by 73
Metadata
- Authors
- Currie, C. J., Poole, C. D., Woehl, A., Morgan, C. L., Cawley, S., Rousculp, M. D., Covington, M. T., & Peters, J. R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2007-01-26
- Volume
- 24
- Issue
- 2
- Pages
- 187-194
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2029012280
- Cited by
- 61
- References
- 0
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. https://app.cochat.ai/papers/10.1111/j.1464-5491.2006.02057.x
- The paper
- Currie, C. J., Poole, C. D., Woehl, A., Morgan, C. L., Cawley, S., Rousculp, M. D., Covington, M. T., & Peters, J. R. (2007). The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2006.02057.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.